PAMU
PTCT icon

Pictet Asset Management (UK)’s PTC Therapeutics PTCT Stock Holding History

Pictet Asset Management (UK)’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$19.4M Sell
459,087
-35,926
-7% -$1.54M 0.02% 531
2021
Q1 		$23.4M Buy
495,013
+96,418
+24% +$5.73M 0.03% 474
2020
Q4 		$24.3M Sell
398,595
-85,182
-18% -$5.02M 0.03% 439
2020
Q3 		$22.6M Sell
483,777
-292,583
-38% -$14.4M 0.04% 412
2020
Q2 		$39.4M Buy
776,360
+159,524
+26% +$7.84M 0.07% 288
2020
Q1 		$27.5M Sell
616,836
-280,775
-31% -$14.1M 0.06% 308
2019
Q4 		$43.1M Sell
897,611
-264,164
-23% -$11.2M 0.08% 299
2019
Q3 		$39.3M Buy
1,161,775
+39,302
+4% +$1.71M 0.08% 268
2019
Q2 		$50.5M Buy
1,122,473
+725,997
+183% +$28.7M 0.11% 230
2019
Q1 		$14.9M Buy
396,476
+109,206
+38% +$3.67M 0.03% 458
2018
Q4 		$9.86K Buy
287,270
+72,477
+34% +$2.61M 0.02% 510
2018
Q3 		$10.1M Buy
214,793
+161,393
+302% +$6.68M 0.02% 560
2018
Q2 		$1.8M Buy
53,400
+3,300
+7% +$103K ﹤0.01% 813
2018
Q1 		$1.36M Buy
+50,100
New +$1.27M ﹤0.01% 818
2016
Q3 		– Sell
-1,329,215
Closed -$10.8M – 846
2016
Q2 		$10.8M Buy
1,329,215
+1,023,180
+334% +$7.5M 0.04% 414
2016
Q1 		$2.44M Buy
306,035
+42,847
+16% +$744K 0.01% 663
2015
Q4 		$8.53M Buy
263,188
+65,644
+33% +$1.93M 0.04% 437
2015
Q3 		$5.27M Buy
197,544
+8,220
+4% +$352K 0.02% 542
2015
Q2 		$9.7M Buy
189,324
+62,646
+49% +$3.65M 0.04% 430
2015
Q1 		$7.44M Sell
126,678
-73,508
-37% -$4.48M 0.03% 490
2014
Q4 		$10.4M Buy
200,186
+121,786
+155% +$5.36M 0.05% 397
2014
Q3 		$3.45M Sell
78,400
-4,500
-5% -$141K 0.02% 638
2014
Q2 		$2.17M Buy
82,900
+23,500
+40% +$503K 0.01% 728
2014
Q1 		$1.55M Buy
+59,400
New +$1.6M 0.01% 760

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Pictet Asset Management (UK)'s PTCT Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its PTC Therapeutics (PTCT) stake by 7.3% in Q2 2021, selling an estimated $1.54M and leaving 459,087 shares worth $19.4M. The position accounts for 0.02% of the portfolio, ranked #531.

Pictet Asset Management (UK) first reported a position in PTCT in Q1 2014 and has held it in 24 quarters since. The position peaked at $50.5M in Q2 2019. 182 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

  • Pictet Asset Management (UK) held 459,087 shares of PTC Therapeutics worth $19.4M as of Q2 2021.
  • Pictet Asset Management (UK) sold 35,926 PTC Therapeutics shares in Q2 2021, an estimated $1.54M.
  • PTC Therapeutics made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #531 holding.
  • Pictet Asset Management (UK) first reported a position in PTC Therapeutics in Q1 2014 and has held it in 24 quarters since.
  • Pictet Asset Management (UK)'s PTC Therapeutics position peaked at $50.5M in Q2 2019.
  • 182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.